Page d'accueil  |  Aide  |  Effacer
Anglais  |  Français
 Rechercher  |  Catégories  |  Titres A-Z  |  Pays  |  Comparer pays  |  Index  
Etendre sommaire
Document complet
Dérouler chapitre
Préférences

fermer ce livreDrugs Formulary for District Hospitals - Ethiopia (DACA; 2004; 322 pages)
Afficher le documentACKNOWLEDGEMENTS
Afficher le documentINTRODUCTION
Afficher le documentGENERAL ADVICE TO PRESCRIBERS
ouvrir ce répertoire et afficher son contenu1. DRUGS ACTING ON THE GASTROINTESTINAL SYSTEM
ouvrir ce répertoire et afficher son contenu2. CARDIOVASCULAR DRUGS
ouvrir ce répertoire et afficher son contenu3. RESPIRATORY DRUGS
fermer ce répertoire4. CENTRAL NERVOUS SYSTEM DRUGS
Afficher le document4.1. Analgesics / Antipyretics
Afficher le document4.2. Sedatives, Hypnotics and Tranquillizers
Afficher le document4.3. Antidepressants
Afficher le document4.4. Anticonvulsants
Afficher le document4.5. Antiparkinson Agents
ouvrir ce répertoire et afficher son contenu5. DRUGS USED IN ANESTHESIA
ouvrir ce répertoire et afficher son contenu6. DRUGS USED IN MUSCLOSKELETAL AND JOINT DISEASE
ouvrir ce répertoire et afficher son contenu7. ANTI-INFECTIVE
ouvrir ce répertoire et afficher son contenu8. DRUGS USED IN ENDOCRINE DISORDERS AND CONTRACEPTIVES.
Afficher le document9. OBSTETRIC AND GYNAECOLOGICAL MEDICATIONS
ouvrir ce répertoire et afficher son contenu10. BLOOD PRODUCTS AND DRUGS AFFECTING THE BLOOD
ouvrir ce répertoire et afficher son contenu11. DRUGS FOR CORRECTING WATER, ELECTROLYTE AND ACID - BASE DISTURBANCES
ouvrir ce répertoire et afficher son contenu12. VITAMINS
ouvrir ce répertoire et afficher son contenu13. ANTIHISTAMINES AND ANTIALLERGICS
ouvrir ce répertoire et afficher son contenu14. OPHTHALMIC AGENTS
ouvrir ce répertoire et afficher son contenu15. EAR, NOSE, AND THROAT PREPARATIONS
ouvrir ce répertoire et afficher son contenu16. DERMATOLOGIC AGENTS
Afficher le document17. ANTIDOTES AND OTHER SUBSTANCES USED IN POISONING
Afficher le document18. IMMUNOLOGICAL PREPARATIONS
Afficher le document19. MISCELLANEOUS
Afficher le documentAPPENDIXES
Afficher le documentGLOSSARY
Afficher le documentBACK COVER
 

4.5. Antiparkinson Agents

Antimuscarinic agents are used in parkinson's disease (idiopathic or primary parkinsonism) and drug - induced Parkinsonism. Those commonly used are the tertiary amine, benzhexol hydrochloride, benztropine mesylate, orphenadrine hydrochloride, and procyclidine hydrochloride.

In Parkinson's disease, antimuscarinics are generally used in the early stages when the condition is mild and tremor is the predominant symptom as they provide little benefit in bradykinesia. They can also reduce the diarrhoea experienced by patients with this disease.

Antimuscarinics are also used as adjuvant therapy with levodopa plus adopa - decarboxylase inhibitor to reduce or prevent levodopa - induced adverse effects including the "on - off" phenomenon.

Tardive dyskinesia is not improved by the antimuscarinic drugs and may be made worse.

Benzhexol (Trihexyphenidyl Hydrochloride)
Tablet, 2mg, 5mg

Indications: - Parkinsonism; drug induced extrapyramidal symptoms (but not tardive dyskinesia).

Cautions: - as antimuscarinics in general (see section 1.3), and cardiovascular disease, hepatic or renal impairment; elderly, avoid abrupt discontinuation of treatment; liable to abuse (may produce euphoric effect); interactions

Drug interactions, Side effects: - as antimuscarinics in general (see section 1.3)

Contraindications: - untreated urinary retention, angle-closure glaucoma, gastrointestinal obstruction.

Dose and Administration

1 mg daily, increased gradually; usual maintenance dose 5 - 15mg daily in 3 - 4 divided doses; elderly preferably lower end of range.

Storage: - at room temperature in a tight container.

Benztropine (Mesylate)
Tablet, 2mg
Injection, 1mg/ml in 2ml ampoule

Indications, Caution, Drug interactions; see Trihexyphenidyl hydrochloride

Side effects: see trihexypenidyl Hydrochloride, but causes sedation rather than stimulation.

Contraindications: see Trihexyphenidyl Hydrochloride; avoid in children less than 3 years.

Dose and Administration:

By mouth, 0.5 - 1mg daily usually at bedtime, generally increased, max. 6mg daily; usual maintenance dose 1 - 4mg daily in single or divided dose; elderly preferably lower end of range.

By intramuscular or intravenous injection, 1 - 2mg repeated if symptoms reappear; Elderly preferably lower end of range.

Storage: - at room temperature in a well-closed container. Protect from freezing.

vers la section précédentevers la section suivante

S'il vous plaît envoyez vos commentaires Anglais  |  Français